Who owns LENZ THERAPEUTICS INC?
- CUSIP Number: 52635n103
Tip: Access positions for across all investors
Analyze quarterly positions in Lenz Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lenz Therapeutics stock
Who bought or sold LENZ THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 4.2M | $93M | 100% | Mar 2024 |
|
| EcoR1 Capital | 1.2M | $27M | 100% | Mar 2024 |
|
| Samsara BioCapital | 1.2M | $27M | 100% | Mar 2024 |
|
| 72 Investment Holdings | 1.0M | $23M | 100% | Mar 2024 |
|
| Point72 Asset Management | 865k | $19M | 100% | Mar 2024 |
|
| Tang Capital Management | 548k | $12M | 100% | Mar 2024 |
|
| BlackRock | 241k | $5.4M | 100% | Mar 2024 |
|
| Vanguard Group | 207k | $4.6M | 100% | Mar 2024 |
|
| Alyeska Investment Group | 200k | $4.4M | 100% | Mar 2024 |
|
| Jennison Associates | 135k | $3.0M | 100% | Mar 2024 |
|
| Board of Trustees of The Leland Stanford Junior University | 100k | $2.2M | 100% | Mar 2024 |
|
| Geode Capital Management | 88k | $2.0M | 100% | Mar 2024 |
|
| Ikarian Capital | 85k | $1.9M | 100% | Mar 2024 |
|
| Prosight Management | 65k | $1.5M | 100% | Mar 2024 |
|
| BML Capital Management | 64k | $1.4M | 100% | Mar 2024 |
|
| Vivaldi Capital Management | 59k | $924k | 100% | Mar 2024 |
|
| Northern Trust | 41k | $908k | 100% | Mar 2024 |
|
| Jacobs Levy Equity Management | 37k | $830k | 100% | Mar 2024 |
|
| Acuitas Investments | 32k | $703k | 100% | Mar 2024 |
|
| Morgan Stanley | 27k | $608k | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 24k | $526k | 100% | Mar 2024 |
|
| Boothbay Fund Management | 23k | $505k | 100% | Mar 2024 |
|
| Bridgeway Capital Management | 22k | $490k | 100% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 16k | $362k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 12k | $261k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 11k | $250k | 100% | Mar 2024 |
|
| CornerCap Investment Counsel | 9.4k | $209k | 100% | Mar 2024 |
|
| Barclays | 6.6k | $147k | 100% | Mar 2024 |
|
| Marquette Asset Management | 5.9k | $131k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 4.6k | $103k | 100% | Mar 2024 |
|
| UBS Group | 4.3k | $95k | 100% | Mar 2024 |
|
| Bank of America Corporation | 3.9k | $88k | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 3.5k | $78k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 1.7k | $38k | 100% | Mar 2024 |
|
| FMR | 1.4k | $31k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 1.4k | $30k | 100% | Mar 2024 |
|
| Qube Research & Technologies | 982.00 | $22k | 100% | Mar 2024 |
|
| Citigroup | 750.00 | $17k | 100% | Mar 2024 |
|
| NISA Investment Advisors | 644.00 | $14k | 100% | Mar 2024 |
|
| Group One Trading | 571.00 | $13k | 100% | Mar 2024 |
|
| California State Teachers Retirement System | 454.00 | $10k | 100% | Mar 2024 |
|
| Tower Research Capital | 451.00 | $10k | 100% | Mar 2024 |
|
| Legal & General Group | 382.00 | $8.5k | 100% | Mar 2024 |
|
| Summit Investment Advisors | 331.00 | $7.4k | 100% | Mar 2024 |
|
| Amalgamated Bank | 135.00 | $3.0k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 93.00 | $0 | 100% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 28.00 | $624.999200 | 100% | Mar 2024 |
|
| Advisor Group Holdings | 2.00 | $45.000000 | 100% | Mar 2024 |
|